Cobra Biologics Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 142

Employees

  • Latest Deal Type
  • Later Stage VC

  • Financing Rounds
  • 6

  • Investments
  • 1

Cobra Biologics General Information

Description

Provider of pharmaceutical and biotechnology research services. The company is a contract service provider supporting pharmaceutical companies and biotechnology companies in the development and manufacture of mammalian cell-culture-derived products for clinical trials.

Contact Information

Formerly Known As
Recipharm Biotech, AstraZeneca Biotech Laboratory, Recipharm Biologics
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Stephenson Building
  • The Science Park
  • Keele ST5 5SP
  • England, United Kingdom
+44 01782
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Stephenson Building
  • The Science Park
  • Keele ST5 5SP
  • England, United Kingdom
+44 01782

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cobra Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cobra Biologics‘s full profile, request access.

Request a free trial

Cobra Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of pharmaceutical and biotechnology research services. The company is a contract service provider supporting ph
Biotechnology
Keele, United Kingdom
142 As of 2023

Durham, NC
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cobra Biologics Competitors (13)

One of Cobra Biologics’s 13 competitors is KBI BioPharma, a Formerly VC-backed company based in Durham, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
KBI BioPharma Formerly VC-backed Durham, NC
Lonza Group Corporation Basel, Switzerland
Fujifilm Diosynth Biotechnologies Corporate Backed or Acquired College Station, TX
CordenPharma Private Equity-Backed Plankstadt, Germany
WuXi AppTec Formerly PE-Backed Shanghai, China
You’re viewing 5 of 13 competitors. Get the full list »

Cobra Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cobra Biologics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cobra Biologics‘s full profile, request access.

Request a free trial

Cobra Biologics Acquisitions (1)

Cobra Biologics’s most recent deal was a Merger/Acquisition with Unitech Pharma. The deal was made on 31-Oct-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Unitech Pharma 31-Oct-2011 Merger/Acquisition Pharmaceuticals
To view Cobra Biologics’s complete acquisitions history, request access »

Cobra Biologics FAQs

  • When was Cobra Biologics founded?

    Cobra Biologics was founded in 1992.

  • Where is Cobra Biologics headquartered?

    Cobra Biologics is headquartered in Keele, United Kingdom.

  • What is the size of Cobra Biologics?

    Cobra Biologics has 142 total employees.

  • What industry is Cobra Biologics in?

    Cobra Biologics’s primary industry is Biotechnology.

  • Is Cobra Biologics a private or public company?

    Cobra Biologics is a Private company.

  • What is Cobra Biologics’s current revenue?

    The current revenue for Cobra Biologics is .

  • Who are Cobra Biologics’s investors?

    AstraZeneca, Flerie, and Recipharm have invested in Cobra Biologics.

  • Who are Cobra Biologics’s competitors?

    KBI BioPharma, Lonza Group, Fujifilm Diosynth Biotechnologies, CordenPharma, and WuXi AppTec are some of the 13 competitors of Cobra Biologics.

  • When was Cobra Biologics acquired?

    Cobra Biologics was acquired on 21-Oct-2021.

  • Who acquired Cobra Biologics?

    Cobra Biologics was acquired by Cognate Bioservices.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »